![Per Walday](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Per Walday
Vorstandsvorsitzender bei EXACT THERAPEUTICS
Vermögen: 1 833 $ am 31.05.2024
Profil
Per Walday is currently the Chief Executive Officer at EXACT Therapeutics AS since 2022.
Previously, he served as the Chief Executive Officer at PCI Biotech Holding ASA from 2008 to 2022.
He also worked at GE Healthcare AS as the Global Head-Project Management.
Dr. Walday holds a doctorate degree from the University of Oslo.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
EXACT THERAPEUTICS AS
0,01% | 04.01.2023 | 2 500 ( 0,01% ) | 1 833 $ | 31.05.2024 |
Aktive Positionen von Per Walday
Unternehmen | Position | Beginn |
---|---|---|
EXACT THERAPEUTICS | Vorstandsvorsitzender | 06.06.2022 |
Ehemalige bekannte Positionen von Per Walday
Unternehmen | Position | Ende |
---|---|---|
PCI BIOTECH HOLDING ASA | Vorstandsvorsitzender | 31.05.2022 |
GE Healthcare AS
![]() GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Corporate Officer/Principal | - |
Ausbildung von Per Walday
University of Oslo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
PCI BIOTECH HOLDING ASA | Health Technology |
EXACT THERAPEUTICS | Health Technology |
Private Unternehmen | 1 |
---|---|
GE Healthcare AS
![]() GE Healthcare AS Medical SpecialtiesHealth Technology GE Healthcare AS markets contrast agent for x-ray, ultrasound, Magnetic Resonance Imaging, and radiopharmaceuticals for clinicians to predict, diagnose, inform, and treat diseases. The company was founded on September 07, 1981 and it is headquartered in Oslo, Norway. | Health Technology |